{"product_id":"myjvm-pestle-analysis","title":"JVM PESTLE Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSkip the Research. Get the Strategy.\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eDiscover how political shifts, economic cycles, and rapid tech change are reshaping JVM’s competitive landscape—our concise PESTLE highlights immediate risks and opportunities to inform smarter strategy and investment choices; purchase the full report for the complete, actionable breakdown ready for boardrooms and due diligence.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eolitical factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGovernment healthcare subsidies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMany governments increased funding for healthcare automation, with EU recovery and US federal grants allocating over €3.2bn and $2.1bn respectively for digital hospital upgrades by late 2025, prioritizing automated dispensing to cut medication errors. Targeted subsidy programs in Germany, France and Canada offered pharmacy grants covering 30–70% of automation costs, accelerating adoption. JVM can tap these incentives to subsidize pilot deployments and reduce client CAPEX, lowering the barrier to entry for new hospital contracts.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eExport trade agreements\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eChanges in international trade protocols directly affect JVM’s global distribution from South Korea, where exports accounted for about 68% of revenue in 2024; tighter rules could raise logistics costs by 4–7%. Favorable trade terms with the EU and US—South Korea-EU FTA tariff eliminations and a 2024 Korea-US trade dialogue—reduce tariffs, smoothing customs and cutting landed costs an estimated 3–5%. Analysts track geopolitical shifts to gauge JVM’s competitive pricing versus local manufacturers, noting a 2024 average price premium of 8% that could narrow if tariffs shift or shipping rates spike.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eNational pharmacy labor policies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eLegislative moves in 2024–25 limiting pharmacist shifts and mandating break\/monitoring rules have accelerated political support for automation; several US states and EU nations report proposals reducing weekly hours by up to 10–15%, raising labor cost pressure on pharmacies.\u003c\/p\u003e\n\u003cp\u003ePublic health agencies now frame automated pouch packaging as a risk-mitigation tool after studies linking exhaustion to 20–30% higher dispensing errors, prompting inclusion in draft guidelines in at least 8 countries.\u003c\/p\u003e\n\u003cp\u003eSuch regulatory endorsement creates a stable tailwind for JVM: automated pouch systems address compliance and safety metrics, supporting predictable demand and favorable reimbursement or grant programs that can offset initial CAPEX.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal healthcare infrastructure funding\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003ePolitical commitments to modernize healthcare infrastructure in emerging markets—supported by multilateral loans totaling over $40bn in 2024—create a sizable growth runway for JVM.\u003c\/p\u003e\n\u003cp\u003eAs countries build centralized hospital networks, procurement of high-volume automated dispensing systems grows; hospital capital expenditure in Africa and SE Asia rose ~12% CAGR 2019–2024.\u003c\/p\u003e\n\u003cp\u003eJVM times market entry with state-led cycles, capturing tenders that favor technologically modern suppliers and often secure multi-year contracts worth $5–50m each.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMultilateral funding \u0026gt;$40bn (2024)\u003c\/li\u003e\n\u003cli\u003eHospital capex +12% CAGR (2019–2024)\u003c\/li\u003e\n\u003cli\u003eTender sizes typically $5–50m\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGeopolitical supply chain stability\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eGeopolitical tensions between Taiwan, China, and the US—responsible for roughly 70% of global semiconductor production—threaten JVMs’ supply of sensors and controllers; 2024 disruptions raised component lead times by ~40% and added 8–12% to BOM costs for industrial machines.\u003c\/p\u003e\n\u003cp\u003eManagement should diversify suppliers across SE Asia and Europe and hold strategic inventory equal to 3–6 months of critical parts to mitigate 2024-25 risk and cap cost volatility.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e70% semiconductor concentration in Taiwan\/US\/China\u003c\/li\u003e\n\u003cli\u003e~40% longer lead times in 2024\u003c\/li\u003e\n\u003cli\u003e8–12% BOM cost increase\u003c\/li\u003e\n\u003cli\u003eMaintain 3–6 months strategic inventory\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGrants, subsidies and loans fuel JVM adoption amid export and logistics risk\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePolitical support via EU\/US grants (€3.2bn \/ $2.1bn by 2025) and national subsidies (30–70% CAPEX) lowers adoption barriers for JVM; trade FTAs cut landed costs ~3–5% while export exposure (68% revenue from S Korea, 2024) faces 4–7% logistics risk if protocols tighten; multilateral loans \u0026gt;$40bn (2024) and hospital capex +12% CAGR (2019–2024) expand tender opportunities ($5–50m each).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eEU\/US grants\u003c\/td\u003e\n\u003ctd\u003e€3.2bn \/ $2.1bn (by 2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSubsidy coverage\u003c\/td\u003e\n\u003ctd\u003e30–70% CAPEX\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eExport exposure (S Korea)\u003c\/td\u003e\n\u003ctd\u003e68% revenue (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMultilateral loans\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;$40bn (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHospital capex CAGR\u003c\/td\u003e\n\u003ctd\u003e+12% (2019–2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTender size\u003c\/td\u003e\n\u003ctd\u003e$5–50m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eExplores how external macro-environmental factors uniquely affect the JVM across six dimensions—Political, Economic, Social, Technological, Environmental, and Legal—backed by current data and trends to identify threats, opportunities, and forward-looking scenarios for executives and investors.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eProvides a concise, visually segmented PESTLE snapshot of the JVM landscape for quick reference in meetings or presentations, easing alignment on external risks and strategic positioning.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eE\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003economic factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRising healthcare expenditure\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGlobal healthcare spending rose to an estimated $11.3 trillion in 2024 and continues to outpace GDP in many developed economies into 2025, prompting hospitals and pharmacies to prioritize long-term cost reductions via automation.\u003c\/p\u003e\n\u003cp\u003eJVM's automation systems address this demand by cutting manual labor and medication waste, with case studies showing potential operational savings of 15–30% and payback periods under 3 years.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCurrency exchange rate fluctuations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAs a major exporter, JVM's profitability is sensitive to KRW fluctuations versus USD and EUR; KRW strengthened ~6% vs USD and ~4% vs EUR in 2024, which can compress export margins. A stronger won makes JVM's products pricier for international buyers, risking lower sales volume in price-sensitive markets where JVM had 42% of revenue in 2024. Financial teams monitor FX and used hedges—forward contracts covered ~55% of 2024 expected FX exposure—to mitigate revenue risk.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLabor cost inflation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eRising skilled labor costs in pharmaceuticals—US pharmacist median wage up 7.4% to about $68\/hr in 2024 and pharmacy technician wages up ~6%—increase operating expenses, making JVM automated dispensing systems more attractive as they shorten payback periods; recent case studies show automation can cut labor hours by 30–50%, reducing annual payroll costs by $60k–$120k per 1–2 store deployment.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHospital capital expenditure budgets\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eHospital capex budgets tightened as global policy rates averaged ~4.5% in 2024–25, pushing hospital borrowing costs up and delaying ~$12–18bn of US hospital tech investments in 2024 per Kaufman Hall estimates; smaller clinics saw financing costs rise 150–300bps, slowing large-scale automation buys.\u003c\/p\u003e\n\u003cp\u003eJVM should offer leasing, pay-per-use, and 36–60 month financing with subsidy assistance to offset tight credit and preserve deal flow.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eHigh rates (~4.5% avg 2024–25) raised borrowing costs 150–300bps for smaller clinics\u003c\/li\u003e\n\u003cli\u003eEstimated $12–18bn of US hospital tech investments deferred in 2024 (Kaufman Hall)\u003c\/li\u003e\n\u003cli\u003eFlexible leasing, pay-per-use, 36–60 month finance advisable\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal supply chain costs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eFluctuations in raw material prices—steel up ~18% year-over-year and engineered plastics up ~12% in 2024—raise JVM dispensing-hardware costs and squeeze margins.\u003c\/p\u003e\n\u003cp\u003eGlobal shipping rates, with container spot rates down ~40% from 2022 but still volatile, add delivery-cost uncertainty to international pricing.\u003c\/p\u003e\n\u003cp\u003eRobust supply-chain strategies (nearshoring, multi-sourcing, hedging) are essential for JVM to protect margins amid these swings.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eSteel +18% YoY (2024)\u003c\/li\u003e\n\u003cli\u003eEngineered plastics +12% (2024)\u003c\/li\u003e\n\u003cli\u003eContainer spot rates ~40% below 2022 but volatile\u003c\/li\u003e\n\u003cli\u003eMitigation: nearshoring, multi-sourcing, hedging\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHealthcare $11.3T Spurs JVM Automation: 15–30% Ops Cuts, FX \u0026amp; Input-Cost Risks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eHealthcare spend hit $11.3T in 2024, driving demand for cost-cutting automation where JVM saves 15–30% ops costs with \u0026lt;3-year paybacks; export revenue (42% in 2024) is FX-sensitive as KRW strengthened ~6% vs USD and ~4% vs EUR in 2024, with ~55% hedged via forwards; rising input costs (steel +18%, engineered plastics +12% YoY 2024) and ~40% lower-but-volatile container rates pressure margins—offer leasing\/36–60m financing to sustain deals.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\/2025\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eGlobal healthcare spend\u003c\/td\u003e\n\u003ctd\u003e$11.3T (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eJVM export revenue\u003c\/td\u003e\n\u003ctd\u003e42% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eKRW vs USD\/EUR\u003c\/td\u003e\n\u003ctd\u003e+6% \/ +4% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHedged FX exposure\u003c\/td\u003e\n\u003ctd\u003e~55% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOperational savings\u003c\/td\u003e\n\u003ctd\u003e15–30%, payback \u0026lt;3y\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSteel \/ plastics YoY\u003c\/td\u003e\n\u003ctd\u003e+18% \/ +12% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eFull Version Awaits\u003c\/span\u003e\u003cbr\u003eJVM PESTLE Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown here is the exact JVM PESTLE Analysis document you’ll receive after purchase—fully formatted, professionally structured, and ready to use; no placeholders or surprises. What you see is the real file you’ll download immediately after payment, with the same layout, content, and structure displayed in this preview. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56751837610361,"sku":"myjvm-pestle-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/myjvm-pestle-analysis.png?v=1772235215","url":"https:\/\/matrixbcg.com\/products\/myjvm-pestle-analysis","provider":"MatrixBCG","version":"1.0","type":"link"}